Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief Hero Image

Pharmaceutical & Biotech

Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief

Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population.

Released Thursday, March 25, 2021

Subscribe to our Newsletter

Reports related to this article:

Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population. Pfizer-BioNTech is primarily producing the vaccine at Pfizer's facility in Kalamazoo, Michigan. Moderna and Johnson & Johnson are contracting out much of their COVID-19 vaccine manufacturing to Catalent, using its facility in Bloomington, Indiana.

As of March 23, about one in four Americans had received at least their first COVID-19 vaccine dose.

Attachment
/iirenergy/industry-news/article.jsp false

Share This Article

Want More IIR News Intelligence?

Make us a Preferred Source on Google to see more of us when you search.

Add Us On Google

Please verify you are not a bot to enable forms.

What is 62 + 6?

Ask Us

Have a question for our staff?

Submit a question and one of our experts will be happy to assist you.

By submitting this form, you give Industrial Info permission to contact you by email in response to your inquiry.

A glowing computer chip is placed on a dark blue circuit board. Bright blue lines and nodes create a futuristic, technological ambiance.

Explore Our EnergyLive Tools

EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.

Explore Our Tools
Dimly lit data center with rows of towering black server racks, glowing blue lights, and a sleek, futuristic ambiance.

Explore Our Enery Industry Reports

Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.

View Reports